MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Glooko, the leader in diabetes data management, announced today its mobile app (available for Android and iOS) is now free* for any person with diabetes. Previously, there was a subscription fee for individuals not sponsored through their provider, health plan, or employer. The mobile app can help users effectively self-manage their condition through glucose tracking, insights delivery and by correlating food, exercise and medication data to create actionable insights. For healthcare providers who use Glooko for remote monitoring, their entire patient population now will be available for them to provide this service. Glooko remote monitoring programs have been demonstrated to help participants improve outcomes, including improving average blood glucose by 12% and reducing the occurrence of hyperglycemia by 15%**; this change allows a broader population to experience these clinical benefits.
Remote monitoring also offers providers the ability to have efficient in-clinic appointments, as patients can sync their device data at home rather than doing so in the office, as well as access new revenue streams via newly available CPT codes for remote patient monitoring. These codes provide reimbursement for key tasks required to remotely monitor patients, including training patients, collecting and monitoring remotely synced data, and communicating with patients about changes to their treatment plan based on the data they sync remotely.
“Glooko strives to improve the lives of people with diabetes by providing actionable insights to inform care decisions,” said Russ Johannesson, CEO of Glooko. “I am thrilled we are removing the subscription fee for users of the mobile app - this will allow anyone who wants to use Glooko for self-management to be able to do so. I am also excited about the ability for providers to remotely monitor larger patient populations. Diabetes is a very complicated, data-intensive condition; more frequent support for patients is critical in helping them better manage their diabetes.”
All features of the Glooko mobile app will be available in the free version, including the ability to sync data from compatible blood glucose meters, insulin pumps, continuous glucose monitors, and fitness trackers, the ability to log food (including via the recently released barcode scanner), medication, and activity, access to interactive charts and graphs, and the ability to easily send reports to providers and care teams. Glooko also announced today the support for the first implantable long term glucose sensor, the Senseonics Eversense® Continuous Glucose Monitoring System (CGM), available in the free app. Users of the Eversense CGM simply need to connect their Eversense account to Glooko, and their Eversense data will be available along with blood glucose, insulin, food, and any other information logged.
*one-time hardware costs may apply
**improvement after three months for users in Glooko remote monitoring programs with coaching
About Glooko
Glooko’s universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. The Glooko product suite contains the diasend® and Glooko diabetes management solutions, which integrate with many of the leading EHR systems used today. Both systems sync data from 190+ of the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient data such as glucose level, food, insulin, medications, blood pressure and weight data. Trusted by the world’s leaders in diabetes care, our solutions cover more than 2.2 million people with diabetes and are used in 9,000 clinic locations in 23 countries across 15 languages. Learn more by visiting www.glooko.com.